Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus

R. J. Riese, J. G. Teeter, R. D. England (New London, United States Of America)

Source: Annual Congress 2005 - Airway regulation and response I
Session: Airway regulation and response I
Session type: Thematic Poster Session
Number: 3731
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. J. Riese, J. G. Teeter, R. D. England (New London, United States Of America). Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus. Eur Respir J 2005; 26: Suppl. 49, 3731

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Insulin therapy increases airway responsiveness in type 2 diabetes patients
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Effect of inhaled human insulin (EXUBERA®; EXU) vs subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM)
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007


Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008

Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


Risk of development of diabetes mellitus in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006

Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008

Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin
Source: Eur Respir J 2004; 24 : 552-558
Year: 2004



Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012

Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
Source: Annual Congress 2010 - COPD: management
Year: 2010

Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroids
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients
Source: Eur Respir J 2007; 30: Suppl. 51, 365s
Year: 2007

Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroids
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011

Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007